Kemeta

Kemeta was a health technology company that developed a portable breathalyzer for monitoring metabolic health and fat loss. The device measured breath acetone, a biomarker for ketosis, providing users with real-time data on their fat-burning state without the need for invasive blood tests. The company's mission was to empower individuals to optimize their nutrition and fitness through personalized metabolic insights. By correlating breath acetone levels with metabolic efficiency, Kemeta's platform offered a non-invasive alternative to traditional testing methods for those on ketogenic or low-carb diets. The startup was part of the Y Combinator Winter 2016 cohort and targeted the growing consumer biohacking market.